再灌注与急性缺血性卒中脑水肿的关联:MR CLEAN试验二次分析
该研究为MR CLEAN试验的事后分析,纳入462例急性前循环缺血性卒中患者,评估再灌注与中线移位的关系。结果发现成功再灌注和血管再通与中线移位风险降低相关,且中线移位部分介导了未再灌注患者及再灌注延迟或ASPECTS较低患者的不良功能结局。
要点
- 成功再灌注与中线移位风险降低独立相关(校正共同OR 0.25)。
- 血管再通同样与中线移位风险降低相关(校正共同OR 0.34)。
- 中线移位部分解释了未再灌注及再灌注延迟患者的不良功能结局。
核心结论
- 成功再灌注与中线移位减少相关,提示再灌注除挽救缺血组织外,还可能通过减轻水肿带来额外获益。
研究设计与样本
- 研究为MR CLEAN试验的事后分析,该试验为前瞻性随机多中心临床研究,比较血管内治疗与常规治疗。
- 共纳入462例急性前循环缺血性卒中患者,来自2010年12月至2014年6月入组的502例。
- 脑水肿通过随访影像的中线移位回顾性评估,评估者不知道临床数据。
主要发现
- 中线移位部分解释了未再灌注或未再通患者较差的mRS评分(回归系数变化分别为30.3%和12.6%)。
- 在再灌注延迟或ASPECTS较低的患者中,中线移位部分介导了较差的mRS评分(回归系数变化分别为33.3%和64.2%)。
关键数值与推荐
- 中线移位按有无及连续变量评估。
- 再灌注状态在血管内治疗组用改良脑梗死溶栓评分评估。
- 血管再通状态在两组均用改良动脉闭塞病变评分评估。
- 功能结局用90天改良Rankin量表评分评估。
临床怎么用
- 对于急性前循环缺血性卒中患者,成功再灌注可能有助于减轻脑水肿和中线移位。
- 再灌注延迟或ASPECTS较低时,中线移位部分解释不良结局,提示应尽早实现再灌注。
局限性
- 本研究为事后分析,可能存在残余混杂。
- 中线移位为回顾性评估,且排除了无随访影像或存在实质性血肿的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is uncertain whether therapeutic reperfusion with endovascular treatment yields more or less brain edema. OBJECTIVE: To elucidate the association between reperfusion and brain edema. The secondary objectives were to evaluate whether brain edema could partially be responsible for worse outcomes in patients with later reperfusion or lower Alberta Stroke Program Early Computed Tomography Score. DESIGN, SETTING, AND PARTICIPANTS: This was a post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN), which was a prospective, randomized, multicenter clinical trial of endovascular treatment compared with conventional care of patients with acute anterior circulation ischemic stroke. Of 502 patients enrolled from December 2010 to June 2014, 2 patients declined to participate. Additionally, exclusion criteria were absence of follow-up imaging or presence of parenchymal hematoma, resulting in 462 patients included in this study. Brain edema was assessed retrospectively, from December 10, 2016, to July 24, 2017, by measuring midline shift (MLS) in all available follow-up scans. Observers were blinded to clinical data. MAIN OUTCOMES AND MEASURES: Midline shift was assessed as present or absent and as a continuous variable. Reperfusion status was assessed by the modified thrombolysis in cerebral infarction score in the endovascular treatment arm. The modified arterial occlusive lesion score was used to evaluate the recanalization status in both arms. The modified Rankin scale score at 90 days was used for functional outcome. RESULTS: Of 462 patients, the mean (SD) age was 65 (11) years, and 41.8% (n = 193) were women. Successful reperfusion and recanalization were associated with a reduced likelihood of having MLS (adjusted common odds ratio, 0.25; 95% CI, 0.12-0.53; P < .001 and adjusted common odds ratio, 0.34; 95% CI, 0.21-0.55; P < .001, respectively). Midline shift was partially responsible for worse modified Rankin scale scores in patients without reperfusion or recanalization (MLS changed the logistic regression coefficients by 30.3% and 12.6%, respectively). In patients with delayed reperfusion or lower Alberta Stroke Program Early Computed Tomography Score, MLS mediated part of the worse modified Rankin scale scores, corresponding to a change in the regression coefficient of 33.3% and 64.2%, respectively. CONCLUSIONS AND RELEVANCE: Successful reperfusion was associated with reduced MLS. This study identifies an additional benefit of reperfusion in relation to edema, as well as rescuing ischemic brain tissue at risk for infarction. TRIAL REGISTRATION: Netherlands Trial Registry number: NTR1804 and Current Controlled Trials number: ISRCTN10888758.
引用
- Kimberly WT, Dutra BG, Boers AMM, et al. Association of Reperfusion With Brain Edema in Patients With Acute Ischemic Stroke: A Secondary Analysis of the MR CLEAN Trial. JAMA Neurol. 2018. PMID: 29365017. doi:10.1001/jamaneurol.2017.5162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。